(Q40661158)

22 September 2017

Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders (English)

1 reference

22 September 2017

0 references

1 reference

4

Terence A Ketter

1 reference

22 September 2017

6

Gabriele S Leverich

1 reference

22 September 2017

3

Mark A Frye

1 reference

22 September 2017

10

Robert M Post

1 reference

22 September 2017

5

David A Luckenbaugh

1 reference

22 September 2017

1

Gabriela V Obrocea

1 reference

22 September 2017

Robert M Dunn

2

1 reference

22 September 2017

Andrew M Speer

series ordinal

7

1 reference

22 September 2017

Elizabeth A Osuch

series ordinal

8

1 reference

22 September 2017

Kamal Jajodia

series ordinal

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

22 September 2017

Biological Psychiatry

1 reference

22 September 2017

51

1 reference

22 September 2017

253-260

1 reference

22 September 2017

3

1 reference

Gabapentin in the acute treatment of refractory bipolar disorder.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Methods for reliable longitudinal observation of behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Predictors of response to mood stabilizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Antidepressant effects of lamotrigine in rapid cycling bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Clinical studies on the use of lamotrigine in bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin and motor fluctuations in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Clinical Factors in Lithium Carbonate Prophylaxis Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

An open label study of gabapentin in the treatment of acute mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Episode sequence in bipolar disorder and response to lithium treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Changes in the gene expression of GABAA receptor subunit mRNAs in the septum of rats subjected to pentylenetetrazol-induced kindling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin treatment of mood disorders: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Unanswered questions, unknown future for one of our oldest medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

GABA-stimulated chloride uptake during avian CNS development: modulation by neurosteroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Predictors of recurrence in affective disorder--analyses accounting for individual heterogeneity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gender differences in treatment response to sertraline versus imipramine in chronic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Absence seizures and carbamazepine in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Pharmacologic agents for the treatment of acute bipolar mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin for treatment of pain and tremor: a large case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Outcome of bipolar disorder on long-term treatment with lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Effects of carbamazepine and lithium on affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Double-blind controlled trial of gabapentin in essential tremor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Treatment of social phobia with gabapentin: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin as a potential treatment for anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Beyond lithium in the treatment of bipolar illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Antidepressant effects of carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Bipolar disorder therapeutics: maintenance treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Sex and age differences of neurons expressing GABA-immunoreactivity in the rat bed nucleus of the stria terminalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Depression during mania. Treatment response to lithium or divalproex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A summary of mechanistic hypotheses of gabapentin pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Bipolar depression: pharmacotherapy and related therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

A rating scale for mania: reliability, validity and sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Gabapentin as an adjunctive treatment in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

Clinical predictors of acute response with olanzapine in psychotic mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901206-9

10.1016/S0006-3223(01)01206-9

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference